Literature DB >> 11474355

Maximal versus feigned active cervical motion in healthy patients: the coefficient of variation as an indicator for sincerity of effort.

Z Dvir1, T Prushansky, C Peretz.   

Abstract

STUDY
DESIGN: Maximal and submaximal (feigned) cervical motions in healthy patients were compared.
OBJECTIVE: To test the efficiency of the coefficient of variation in differentiating maximal (sincere) from submaximal (feigned) cervical motion in healthy patients. SUMMARY OF BACKGROUND DATA: Although limitation of cervical motion is a recognized impairment, no well-founded approach for verifying the degree to which a patient is maximizing his or her performance is available currently.
METHODS: A new ultrasound-based system for three-dimensional motion analysis of the head was used to test 25 healthy patients (22 women and 3 men) ages 26 to 48 years. During the first test, (Test 1), the patients were asked initially to move the head maximally at a self-determined velocity in all the primary directions: flexion, extension, right and left rotation, and right and left lateral flexion. They then were presented with a short vignette describing a fictitious accident and asked, using the same protocol, to perform the same types of cervical motions as if they had experienced an injury. No further instructions were provided. A retest (Test 2) in reverse order (feigned effort first) took place 1 to 16 weeks (mean, 3.3 weeks) later.
RESULTS: The range of motion and average velocity were significantly smaller (P = 0.0001) in the feigned than in the maximal performance in all directions and on both tests. Feigned range of motion and velocity also were significantly reduced in Test 2 (P = 0.006), as compared with those in Test 1 (P = 0.0001). The range of motion coefficient of variation in the feigned performance (CVf) remained stable on the retest, but was significantly larger on both tests (P < 0.001) than the corresponding CV derived from maximal performance (CVm). Furthermore, a case-by-case analysis showed that whereas the American Medical Association guidelines identified only 16% of the feigned cases, the use of CVf and CVm resulted in a corresponding rate of 87%. Tolerance intervals at 95% and 99% indicated total separation between the distributions of CVf and CVm, respectively. The average velocity-based CVf and CVm were not of a comparable differentiating power.
CONCLUSIONS: This study indicates that in healthy patients, feigned performance may be differentiated from maximal (sincere) performance effectively and reproducibly using the coefficient of variation.

Entities:  

Mesh:

Year:  2001        PMID: 11474355     DOI: 10.1097/00007632-200108010-00010

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

1.  The effects of protocol and test situation on maximal vs. submaximal cervical motion: medicolegal implications.

Authors:  Zeevi Dvir; Ester Penso-Zabludowski
Journal:  Int J Legal Med       Date:  2003-10-22       Impact factor: 2.686

2.  Co-occurrence of outlet impingement syndrome of the shoulder and restricted range of motion in the thoracic spine--a prospective study with ultrasound-based motion analysis.

Authors:  Christina Theisen; Ad van Wagensveld; Nina Timmesfeld; Turgay Efe; Thomas J Heyse; Susanne Fuchs-Winkelmann; Markus D Schofer
Journal:  BMC Musculoskelet Disord       Date:  2010-06-29       Impact factor: 2.362

3.  Kinematic measures during a clinical diagnostic technique for human neck disorder: inter- and intraexaminer comparisons.

Authors:  Joseph Vorro; Tamara R Bush; Brad Rutledge; Mingfei Li
Journal:  Biomed Res Int       Date:  2013-02-16       Impact factor: 3.411

4.  Altered motor control patterns in whiplash and chronic neck pain.

Authors:  Astrid Woodhouse; Ottar Vasseljen
Journal:  BMC Musculoskelet Disord       Date:  2008-06-20       Impact factor: 2.362

5.  The effects of the Mulligan Sustained Natural Apophyseal Glide (SNAG) mobilisation in the lumbar flexion range of asymptomatic subjects as measured by the Zebris CMS20 3-D motion analysis system.

Authors:  Maria Moutzouri; Evdokia Billis; Nikolaos Strimpakos; Polixeni Kottika; Jacqueline A Oldham
Journal:  BMC Musculoskelet Disord       Date:  2008-10-01       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.